NCT06810492 2025-03-17
The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment
Hubei Cancer Hospital
Phase NA Not yet recruiting
Hubei Cancer Hospital
Columbia University
University of Washington
University of Washington
Roswell Park Cancer Institute
Federal University of São Paulo
Instituto Nacional de Cancerologia de Mexico